Bitcoin halving
What does that mean?
$2.77T
Total marketcap
$108.47B
Total volume
BTC 49.65%     ETH 15.35%
Dominance

Algernon Pharmaceuticals Inc. AGNPD Stock

3.26 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
0 USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Algernon Pharmaceuticals Inc. Price Chart

Algernon Pharmaceuticals Inc. AGNPD Financial and Trading Overview

Algernon Pharmaceuticals Inc. stock price 3.26 USD
Previous Close 3.45 USD
Open 3.15 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 3.15 - 3.55 USD
52 Week Range 2.5 - 32.5 USD
Volume 8.23K USD
Avg. Volume 5.26K USD
Market Cap 6.26M USD
Beta (5Y Monthly) 0.161103
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

AGNPD Valuation Measures

Enterprise Value 3.05M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.5990445
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Algernon Pharmaceuticals Inc. Stock Price History

Beta (5Y Monthly) 0.161103
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 32.5 USD
52 Week Low 2.5 USD
50-Day Moving Average 4.19 USD
200-Day Moving Average 8.41 USD

AGNPD Share Statistics

Avg. Volume (3 month) 5.26K USD
Avg. Daily Volume (10-Days) 6.15K USD
Shares Outstanding 1.67M
Float 1.64M
Short Ratio N/A
% Held by Insiders 1.28%
% Held by Institutions 5.92%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate N/A
Trailing Annual Dividend Yield N/A
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends August 31, 2021
Most Recent Quarter (mrq) August 31, 2021
Next Fiscal Year End August 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -42.88%
Return on Equity (ttm) -72.51%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -7734080 USD
Diluted EPS (ttm) -3.882
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.41M USD
Total Cash Per Share (mrq) 1.44 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 4.802
Book Value Per Share (mrq) 5.442

Cash Flow Statement

Operating Cash Flow (ttm) -7822617 USD
Levered Free Cash Flow (ttm) -4686715 USD

Profile of Algernon Pharmaceuticals Inc.

Country United States
State BC
City Vancouver
Address 700 West Pender Street
ZIP V6C 1G8
Phone N/A
Website https://algernonpharmaceuticals.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188, a psychedelic compound that is part of the tryptamine family for the treatment of ischemic stroke in humans. Algernon Pharmaceuticals Inc. has an agreement with Charles River Laboratories for preclinical studies of AP-188 for the company's stroke clinical research program. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Q&A For Algernon Pharmaceuticals Inc. Stock

What is a current AGNPD stock price?

Algernon Pharmaceuticals Inc. AGNPD stock price today per share is 3.26 USD.

How to purchase Algernon Pharmaceuticals Inc. stock?

You can buy AGNPD shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Algernon Pharmaceuticals Inc.?

The stock symbol or ticker of Algernon Pharmaceuticals Inc. is AGNPD.

Which industry does the Algernon Pharmaceuticals Inc. company belong to?

The Algernon Pharmaceuticals Inc. industry is Biotechnology.

How many shares does Algernon Pharmaceuticals Inc. have in circulation?

The max supply of Algernon Pharmaceuticals Inc. shares is 0.

What is Algernon Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?

Algernon Pharmaceuticals Inc. PE Ratio is 0.00000000 now.

What was Algernon Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?

Algernon Pharmaceuticals Inc. EPS is 0 USD over the trailing 12 months.

Which sector does the Algernon Pharmaceuticals Inc. company belong to?

The Algernon Pharmaceuticals Inc. sector is Healthcare.